Compare CODX & IINN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | CODX | IINN |
|---|---|---|
| Founded | 2013 | 2018 |
| Country | United States | Israel |
| Employees | N/A | N/A |
| Industry | Medical/Dental Instruments | Medical/Dental Instruments |
| Sector | Health Care | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 15.6M | 35.3M |
| IPO Year | 2017 | 2021 |
| Metric | CODX | IINN |
|---|---|---|
| Price | $0.30 | $1.01 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 3 | 1 |
| Target Price | ★ $2.25 | $2.00 |
| AVG Volume (30 Days) | ★ 1.6M | 134.4K |
| Earning Date | 11-13-2025 | 10-01-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $507,892.00 | $289,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | $18.89 | $2,582.74 |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $0.23 | $0.40 |
| 52 Week High | $1.55 | $1.65 |
| Indicator | CODX | IINN |
|---|---|---|
| Relative Strength Index (RSI) | 43.78 | 48.93 |
| Support Level | $0.24 | $0.99 |
| Resistance Level | $0.41 | $1.18 |
| Average True Range (ATR) | 0.03 | 0.07 |
| MACD | -0.01 | -0.01 |
| Stochastic Oscillator | 35.20 | 29.75 |
Co-Diagnostics Inc is a molecular diagnostics company. It develops, licenses, and commercializes molecular technologies such as lab systems (MDx device) and manufacture and sell reagents used for tests that are designed using the detection and/or analysis of nucleic acid molecules (DNA or RNA). CDI's low-cost system uses its tests to diagnose tuberculosis, Zika, hepatitis B and C, Malaria, dengue and HIV.The Company's technologies are utilized for tests that are designed using the detection and/or analysis of nucleic acid molecules (DNA or RNA). The Company also uses its proprietary technology to design specific tests for its Co-Dx PCR platform and to locate genetic markers for use in applications other than infectious diseases.
Inspira Technologies Oxy BHN Ltd is a specialty medical device company engaged in the research, development, manufacture, and marketing of proprietary respiratory support technology that is intended to provide an alternative to invasive mechanical ventilation (MV), which is the standard of care today for the treatment of respiratory failure. The respiratory care devices market is segmented geographically into North America, Europe, the Asia Pacific, Latin America, and the Middle East and Africa.